- Home
- UNCY vs MRLN Comparison
UNCY vs MRLN Comparison
Compare UNCY & MRLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNCY | MRLN |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.1M | 176.9M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | UNCY | MRLN |
|---|---|---|
| Price | $4.59 | $1.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $29.60 | $8.80 |
| AVG Volume (30 Days) | 767.1K | ★ 3.0M |
| Earning Date | 11-11-2026 | 11-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $675,000.00 | N/A |
| Revenue This Year | N/A | $9.23 |
| Revenue Next Year | $52,701.90 | $153.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.93 | $1.70 |
| 52 Week High | $8.74 | $17.00 |
Technical Indicators
Market Signals| Indicator | UNCY | MRLN |
|---|---|---|
| Relative Strength Index (RSI) | 40.81 | 32.66 |
| Support Level | $3.93 | $1.70 |
| Resistance Level | $5.86 | $3.45 |
| Average True Range (ATR) | 0.20 | 0.24 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 38.32 | 12.00 |
Price Performance
Historical ComparisonAbout UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
About MRLN Merlin Inc. Common Stock
Merlin Inc develops software that fulfills the functions of a human pilot in self-flying aircraft to enable both reduced crew and unmanned flight. This technology is designed to be scalable and adaptable across different aircraft types for a growing range of aircraft platforms. The company's aircraft-agnostic, AI-powered software is purpose-built for military and civil programs, and is powering an expanding range of missions and aircraft, through hundreds of autonomous flights from test facilities across the globe. It operates as a single operating and reportable segment.